Cedars-Sinai Accelerator Powered by Techstars launched its third class with companies whose technologies aim to transform the delivery and quality of healthcare. The three-month program aims to provide financial backing, training and exposure to a global entrepreneurial network that can “speed ideas and solutions to the healthcare marketplace.”
Ten startups have been selected, which will develop and refine their products with mentoring from leading Cedars-Sinai physicians, as well as executives from Cedars-Sinai and Techstars. The companies also will receive an initial investment of $120,000 and access to Techstars’ worldwide network of investors, mentors, alumni and corporate partners.
One of the startups, Tasso, makes blood testing simpler and more affordable through its device that allows patients to collect their own blood samples at the push of a button and send to labs for a broad range of diagnostic tests.
Another one, called NarrativeDx, has developed a patient experience management tool that allows facilities to better understand and respond to feedback and concerns by collecting patients’ comments from focus groups, discharge surveys, social media channels and doctor review sites.
Then there’s GYANT, an artificial intelligence bot maker, that uses text messaging or voice-enabled technology to connect with patients and ask about symptoms in a chat setting. Based on responses, it helps identify probable causes of particular conditions and provides information and next steps.
And Lumeon, which automated care pathways allow providers to set up protocols to ensure that patients get the right follow-up care based on advice they’ve received and procedures they’ve undergone. It allows physicians to provide more effective health outcomes at a lower cost.
“The innovations these companies bring to the accelerator have the potential to dramatically improve and streamline the delivery of healthcare,” Darren Dworkin, chief information officer at Cedars-Sinai, said in a statement. “Through this program, these companies will test and improve their ideas. By working with world-class physicians, they will advance their technologies and push their companies to the next level.”
The companies were selected in a competitive process among hundreds of startups around the globe that applied.
Past accelerator participants have achieved notable success, including Stasis Labs, which has successfully deployed a cloud-connected vital signs monitoring system to 12 hospitals across India.; WELL Health, a text messaging platform for patients used by more than 120 physician offices and clinics at Cedars-Sinai; and Deep 6 AI, which uses artificial intelligence to help researchers find patients for clinical trials, and is deploying across Cedars-Sinai.